Drugs / YPEG-Filgrastim
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01238562 | Apr 2010 → Nov 2011 | — | Xiamen Amoytop Biotech Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YPEG-Filgrastim | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01238562 ↗ |
| Route | Subcutaneous | “s.c, single dose of 10mcg/kg of YPEG-Filgrastim” NCT01238562 ↗ |